Related Experiment Videos
Isolated splenic metastasis from endometrial carcinoma
A Giuliani1, A Caporale, M Di Bari
1Istituto I Clinica Chirurgica, Università La Sapienza, Rome, Italy.
Journal of Experimental & Clinical Cancer Research : CR
|June 22, 1999
Summary
Solitary splenic metastasis from endometrial cancer is rare, typically occurring late in disease progression. This case highlights a surgically treated, asymptomatic splenic metastasis detected 28 months post-resection.
Area of Science:
- Oncology
- Surgical Pathology
- Gynecologic Oncology
Background:
- Splenic metastases are uncommon, usually indicating widespread disease.
- Solitary splenic metastases from any primary cancer are rare events.
- Endometrial cancer rarely metastasizes to the spleen.
Purpose of the Study:
- To report a rare case of solitary splenic metastasis from endometrial adenocarcinoma.
- To discuss the clinical presentation and management of this uncommon presentation.
- To contribute to the limited literature on splenic metastases from gynecologic malignancies.
Main Methods:
- Case report of a 58-year-old woman.
- Detection of asymptomatic solitary splenic metastasis 28 months after primary endometrial cancer resection.
- Treatment via splenectomy.
Main Results:
- A solitary, asymptomatic splenic metastasis of endometrial adenocarcinoma was identified.
- The metastasis was detected 28 months after the initial treatment of the primary tumor.
- The patient was successfully treated with splenectomy.
Conclusions:
- Solitary splenic metastasis from endometrial cancer, though rare, can occur.
- Splenectomy is a viable treatment option for isolated splenic metastases.
- This case adds to the understanding of rare metastatic patterns in endometrial cancer.